Related posts:

1. Asthma UK Comment On: Drug Side Effect Linked With Increased Health Risks For Over 65s You may have seen some stories in the media today about a study into the risks of elderly people taking combinations of common medicines, some of which are used to treat asthma and allergies. Cher Piddock, Lead Asthma Nurse at Asthma UK, says: ‘This interesting study highlights the possible risks of combining several common medicines […]...
2. Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
3. Share of Cost, Medi-Cal, Link Between Acetaminophen Use In Adolescents And Doubled Risk Of Asthma New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with a 50 percent increase in the risk of asthma....
4. Share of Cost, Guide to Help Small Business Owners Understand How New ADA Regulations Apply to Them Share of Cost, Guide to Help Small Business Owners Understand How New ADA Regulations Apply to Them...
5. Asthma And Eczema Sufferers Have A Lower Risk Of Developing A Cancer Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRS Institut Armand-Frappier, the Research Centre of the Centre hospitalier de l’Université de Montréal, and McGill University…...
6. Desensitisation Approaches Effective Against Hayfever-Like Allergies Desensitisation Approaches Effective Against Hayfever-Like Allergies...
7. Share of Cost, Release Of Official Food Allergy Treatment Guidelines – Protocol Also Designed To Aid Physicians In Diagnosis Share of Cost, Release Of Official Food Allergy Treatment Guidelines - Protocol Also Designed To Aid Physicians In Diagnosis...
8. FDA Approves NEXIUM(R) I.V. (Esomeprazole Sodium) For The Treatment Of GERD With Erosive Esophagitis In Pediatric And Adolescent Patients AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM® I.V. (esomeprazole sodium) for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis when oral therapy is not possible or appropriate.1 NEXIUM I.V....
9. Ten Steps To A Safe School Year For Kids With Allergies And Asthma For millions of children with allergies and asthma, heading back-to-school with high levels of fall pollens and molds in the air and exposure to potential allergens and viruses in class can really take a toll… Find an affordable dental plan here!...
10. Step-by-Step Guide to Buying a Medigap Policy Step-by-Step Guide to Buying a Medigap Policy...
11. Parents Of Students With Asthma And Allergies, How Do You Know When Your Child Is Ready To Self-Medicate At School? Students with asthma and allergies will pack more than just a lunchbox and bookbag when they start school this year: They’ll be devising ways to keep their life-saving medications close at hand should they need them. No longer do they have to be locked up in the nurse’s cabinet or the office…...
12. Modern Treatments For GERD Effective At Achieving Long-Term Remission For Most Patients In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA....
13. Share of Cost, Allergy Shots Are Helpful For Some Asthmatics, Risky For Others Allergy shots can reduce symptoms of asthma, use of inhaled medications and allergy-related asthma attacks, confirms an updated review of studies. Yet, the treatment can also cause systemic side effects that range from a stuffy nose to fatal anaphylactic shock....
14. Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
15. Share of Cost, Multipolar Electrocoagulation Ablation Shown To Be Effective For Barrett’s Esophagus In Long-Term Follow-Up A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett’s esophagus over the long term. No adenocarcinoma (cancer) or high-grade dysplasia of the esophagus developed in any of the study patients....